NCT01919164View on ClinicalTrials.gov

A Study to Investigate the Safety and Effectiveness of Different Doses of Sprifermin in Participants With Osteoarthritis of the Knee

PHASE2CompletedINTERVENTIONAL
Enrollment

549

Participants

Timeline

Start Date

July 29, 2013

Primary Completion Date

May 5, 2016

Study Completion Date

May 7, 2019

Conditions
Osteoarthritis, Knee
Interventions
DRUG

Sprifermin

Participants received Sprifermin as intra-articular injection.

DRUG

Placebo

Participants received Placebo matched to sprifermin as intra-articular injection.

Trial Locations (13)

21201

Research site, Baltimore

Unknown

Research site, Lakewood

Research site, Buenos Aires

Research site, Brno

Research site, Pardubice

Research site, Prague

Research site, Aalborg

Research site, Ballerup Municipality

Research site, Vejle

Research site, Tallinn

Research Site, Hong Kong

Research site, Lodz

Research site, Bucharest

Sponsors

Collaborators (1)

Nordic Bioscience A/S
All Listed Sponsors
collaborator

Nordic Bioscience A/S

INDUSTRY

lead

EMD Serono Research & Development Institute, Inc.

INDUSTRY

NCT01919164 - A Study to Investigate the Safety and Effectiveness of Different Doses of Sprifermin in Participants With Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter